318 related articles for article (PubMed ID: 31833107)
21. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
Guo Y; Zhang Y; Huang W; Selwyn FP; Klaassen CD
BMC Complement Altern Med; 2016 Oct; 16(1):394. PubMed ID: 27756364
[TBL] [Abstract][Full Text] [Related]
22. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
[TBL] [Abstract][Full Text] [Related]
23. Berberine Attenuates Hyperuricemia by Regulating Urate Transporters and Gut Microbiota.
Shan B; Wu M; Chen T; Tang W; Li P; Chen J
Am J Chin Med; 2022; 50(8):2199-2221. PubMed ID: 36266751
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).
Zhang Y; Gu Y; Ren H; Wang S; Zhong H; Zhao X; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Kong P; Hou G; Gao M; Shi Z; Li X; Qiu Y; Zou Y; Yang H; Wang J; Xu G; Lai S; Li J; Ning G; Wang W
Nat Commun; 2020 Oct; 11(1):5015. PubMed ID: 33024120
[TBL] [Abstract][Full Text] [Related]
25. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.
Wang S; Ren H; Zhong H; Zhao X; Li C; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Zou Y; Shi Z; Li X; Li T; Yang H; Lai S; Xu G; Li J; Zhang Y; Gu Y; Wang W
Gut Microbes; 2022; 14(1):2003176. PubMed ID: 34923903
[TBL] [Abstract][Full Text] [Related]
26. Berberine modulates gut microbiota to attenuate cerebral ferroptosis induced by ischemia-reperfusion in mice.
Wang X; Zhang J; Wang S; Song Z; Sun H; Wu F; Lin X; Jin K; Jin X; Wang W; Lin Q; Wang F
Eur J Pharmacol; 2023 Aug; 953():175782. PubMed ID: 37245860
[TBL] [Abstract][Full Text] [Related]
27. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
29. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
Wang Y; Tong Q; Ma SR; Zhao ZX; Pan LB; Cong L; Han P; Peng R; Yu H; Lin Y; Gao TL; Shou JW; Li XY; Zhang XF; Zhang ZW; Fu J; Wen BY; Yu JB; Cao X; Jiang JD
Signal Transduct Target Ther; 2021 Feb; 6(1):77. PubMed ID: 33623004
[TBL] [Abstract][Full Text] [Related]
30. Berberine alleviates intestinal barrier dysfunction in glucolipid metabolism disorder hamsters by modulating gut microbiota and gut-microbiota-related tryptophan metabolites.
Chen Y; Hao Z; Zhao H; Duan X; Jia D; Li K; Yang Y; Cui H; Gao M; Zhao D
J Sci Food Agric; 2023 Feb; 103(3):1464-1473. PubMed ID: 36168925
[TBL] [Abstract][Full Text] [Related]
31. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
Li M; Dang Y; Li Q; Zhou W; Zuo J; Yao Z; Zhang L; Ji G
Sci Rep; 2019 May; 9(1):8003. PubMed ID: 31142783
[TBL] [Abstract][Full Text] [Related]
32. Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens.
Wang C; Yang Y; Chen J; Dai X; Xing C; Zhang C; Cao H; Guo X; Hu G; Zhuang Y
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139133
[TBL] [Abstract][Full Text] [Related]
33. Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.
Yang H; Liu Q; Liu H; Kang X; Tian H; Kang Y; Li L; Yang X; Ren P; Kuang X; Wang X; Guo L; Tong M; Ma J; Fan W
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38466881
[TBL] [Abstract][Full Text] [Related]
34. Responses of human gut microbiota abundance and amino acid metabolism
Fu Y; Wang Y; Wang X; Sun Y; Ren J; Fang B
Food Funct; 2022 Jun; 13(11):6329-6337. PubMed ID: 35611943
[TBL] [Abstract][Full Text] [Related]
35. Berberine regulates intestinal microbiome and metabolism homeostasis to treat ulcerative colitis.
Yang T; Qin N; Liu F; Zhao Y; Liu W; Fan D
Life Sci; 2024 Feb; 338():122385. PubMed ID: 38184271
[TBL] [Abstract][Full Text] [Related]
36. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway.
Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z
Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028
[TBL] [Abstract][Full Text] [Related]
37. Berberine activates PPARĪ“ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma.
Shou JW; Shaw PC
Phytomedicine; 2023 Jul; 115():154842. PubMed ID: 37148713
[TBL] [Abstract][Full Text] [Related]
38. Urinary metabolomics analysis reveals the anti-diabetic effect of stachyose in high-fat diet/streptozotocin-induced type 2 diabetic rats.
Liang L; Liu G; Yu G; Zhang F; Linhardt RJ; Li Q
Carbohydr Polym; 2020 Feb; 229():115534. PubMed ID: 31826396
[TBL] [Abstract][Full Text] [Related]
39. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.
Gupta M; Rumman M; Singh B; Mahdi AA; Pandey S
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1647-1658. PubMed ID: 37704773
[TBL] [Abstract][Full Text] [Related]
40. Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds.
Li M; Shu X; Xu H; Zhang C; Yang L; Zhang L; Ji G
J Transl Med; 2016 Aug; 14(1):237. PubMed ID: 27495782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
